Cochlear Implants Market: Growth, Size, Share, and Trends

Report Code MD 9284
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Cochlear Implants Market by Component Type (Cochlear Implants, Upgrades & Accessories), Type of Implants (Unilateral, Bilateral), Patient Type (Adults, Pediatrics), End User (Hospitals, ENT Clinics) - Global Forecast to 2030

Overview

The global cochlear implants market, valued at US$2.58 billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$2.80 billion in 2024 and an impressive US$4.73 billion by 2030. The cochlear implants market is driven by factors such as the rising prevalence of hearing loss, particularly among the geriatric population, and the growing awareness of hearing rehabilitation options. Additionally, AI-enabled audio processing, pediatrics implantations for speech development, and advancement of surgical techniques create opportunities for better accessibility and improvement in the prognosis. The markets of emerging economies have a host of opportunities regarding developing low-cost implants and also integrating telemedicine for managing the post-implant case.

Cochlear implants Market– Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Cochlear implants Market

Asia Pacific

The market of the Asia Pacific region can be attributed to the presence of a large patient population, widespread insurance coverage, favorable government initiatives, and increasing healthcare investments.

The growing healthcare infrastructure, increasing cases of hearing loss, and the growing geriatric population fuel the market growth.

Emerging markets are expected to offer significant growth opportunities for players operating in the cochlear implants market.

The Asia Pacific market is projected to hold the highest CAGR during the forecast period.

The global cochlear implants market is projected to rise from USD 2.80 billion in 2024 to reach USD 4.73 billion by 2030, at a CAGR of 9.2%.

Global Cochlear implants Market Dynamics

DRIVER: Growing geriatric population

A very critical driver for cochlear implants comes from the fact that the geriatric population is increasing all over the world, increasing demand for effective hearing solutions, including cochlear implants. This population belongs to a section of the demographic that can show severe hearing impairments which could not be treated by regular hearing aids. Cochlear implants give this category of citizens an opportunity for better living and a way of regaining communication to curb social isolation, which again fuels market growth.

The increasing number of older individuals worldwide is significantly driving the demand for cochlear implants. To begin with, considering statistical data provided by the UN Department of Economic and Social Affairs (UN DESA), by the year 2022, more than 10% of inhabitants GLOBALLY have surpassed 65 or more years old - the share that, within next generations of this century, notably in 2030 and further in 2050, the proportion will eventually climb almost to 12% and afterwards as far as to16%, correspondingly. More precisely, according to the reports of WHO, in 2030, one individual of every six at every corner of this world will get at, at least above age sixty years or onwards, and reach the geriatric stage of one's age. With the rise in the global geriatric population, the chances of presbycusis or age-related hearing loss have increased to become a major factor.

RESTRAINT: Surgical risks, procedural complications, and long post-sergery rehabilitation

The invasiveness of the procedure of implantation may discourage treatment, along with possible complications such as infection, failure of devices, and very long recovery due to rehabilitation necessitating continuous auditory training-adaptation-sometimes very harassing for the patient, especially for elderlies.

According to the information provided by the Mayo Clinic, the general complications arising with cochlear implants are less frequent and, among others, include severe meningitis. A bacterial infection develops affecting the membranes covering your brain and spinal cord. Usually, such effects are diminished ahead of the surgeries through vaccinations. Still, all this being possible might weigh on patients and caregivers minds when there is a prospect of undertaking certain surgeries. Other possible complications include bleeding, facial paralysis on the side of the surgery, and infections at the surgical site or involving the implant itself. Such complications add to both the psychological and financial burden in cases of all patients and their families.

Healthline reported in 2023 that reha bilitation was staged and takes a process over time for the brain to adapt itself with the cochlear implant. Logistical and emotional burden from rehabilitation may still be associated with key factors standing against the wide-scale adoption of the technology in cochlear implants.

 

OPPORTUNITY: Integration with digital health platforms

Integration with digital health systems presents a significant possibility for the cochlear implant sector. By incorporating state-of-the-art digital tools like remote monitoring, smartphone apps, and AI-driven hearing optimization, cochlear implants can offer better post-surgery care, real-time adjustments, and customized treatment. This connection can enhance user comfort, improve patient outcomes, and give medical practitioners insightful information for better device management.

Telemedicine presents a promising opportunity to enhance the accessibility and efficiency of cochlear implant care, particularly for patients in remote areas or with limited mobility. The NCBI estimates that, by the year 2022, there are approximately 750,000 individuals in the world who have cochlear implants and require lifelong follow-up care. Many patients must travel great distances for this routine checkup. Care is provided in only 19 centers in the UK, for example, yet telecommunications have emerged as a facilitator of remote programming and follow-up care. Studies in the NCBI report similar hearing outcomes from remote programming sessions as those that were conducted on-site. Visits have also established a very satisfied level among the patients. Hence, this is one of the ways that could help minimize travel burdens, besides offering convenient and cost-effective methods of managing postimplant care.

CHALLENGES: Competition from alternative solutions

The growth of the cochlear implants market is significantly restricted by the availability of alternative solutions and general unawareness about the benefits of the segment. These factors result in a situation in which, despite being substantially useful for hearing restoration, cochlear implants are not used on a wide scale. Subtotal petrosectomy, according to Science Direct, is a valid surgical alternative for patients affected with chronic ear pathology, presence of wide cavities, or implant extrusion.

Other alternatives, aside from cochlear implants, include the conventional hearing aids that amplify sound, bone conduction hearing aids, in which the sound is conducted through the skull, and middle ear implants that directly stimulate the bones in the middle ear. Additionally, there are personal amplifiers and FM systems that aid in enhancing sound quality in specific environments. These offer useful options for those with hearing loss, even if they might not have as many advantages as cochlear implants.

Added to this are major issues of a lack of awareness, which further closes down their adoptions even amongst eligible populations. A study by Thieme estimated that by 2050, approximately 2.5 billion people in the world will have some degree of hearing loss. However, there is a difference in awareness and access for specific demographic groups.

Global Cochlear implants Market Ecosystem Analysis

The cochlear implants market ecosystem includes manufacturers, distributors, and end users of cochlear implants systems. The key manufacturers of cochlear implants products include Cochlear Ltd. (Australia), Sonova (Switzerland), MED-EL Medical Electronics (Austria), Zhejiang Nurotron Biotechnology Co., Ltd. (China), Neubio AG (Switzerland), TODOC Co., Ltd. (South Korea), and Shanghai Listent Medical Tech Co., Ltd. (China). Hello Hearing (Australia) is a distributor in the cochlear implants market. However, John Hopkins Cochlear Implant Center (US), Boys Town National Research Hospital (US), Max Healthcare (India), and Mayo Clinic (US) are among the few end users in the market.

Cochlear implants Market
 

The cochlear implant systems category holds the biggest market share by component type in 2023 and is anticipated to grow at the fastest rate over the course of the forecast period.

The cochlear implant market is divided into two segments: upgrades & accessories and cochlear implant systems. Growth of cochlear implant systems would be facilitated by factors such as the aging population, better awareness regarding the cognitive implications of hearing loss, expanding indications for use, and better access to cochlear implant services. Cochlear implants are intended for individuals with severe-to-profound sensorineural hearing loss in whom damaged inner ear hair cells are unable to detect sound.

Advances in technology have created smaller cochlear implant devices, which are more comfortable with better over-the-ear fits. Even the small electrode which is inserted inside the cochlea was advanced to preserve residual hearing.

The lead markets like China have also witnessed wide diffusion of neonatal newborn hearing screening, which facilitates early intervention and results in better long-term outcomes. Basic medical insurance that covers cochlear implants also serves to accelerate the market growth. In most countries, rapidly increasing awareness about the implant and rising wealth spur the demand for new implants. For instance, the Cochlear Implant Group of India, based on the British Cochlear Implant Group and initiated 15 years ago, has been in the forefront of increasing awareness about cochlear implants and laying down guidelines necessary for their dissemination throughout the country.

Based on end user, the hospitals segment has the largest market share in 2023 and is projected to register the highest CAGR during the forecast period.

Based on end user, the cochlear implants market is divided into hospitals, ENT clinics, and other end users. Hospitals are dominant in the market because of their access to advanced diagnostic equipment, skilled surgical teams, post-implant rehabilitation services, and a wide patient base, including those with severe-to-profound hearing loss. Besides, free cochlear implants under central schemes in some regions add to the demand, thereby making hospitals the favored place for cochlear implant candidates and thus strengthening their dominance in the market.

Growth of the market can be attributed to the growing number of hospitals and increasing demand for cochlear implants. Major economies have focussed on increasing the number of hospitals in their respective healthcare systems. For instance, the number of hospitals in the US today stands at 6,120 compared to 5,129 in 2022. Besides, health care spending in the US grew 4.1% in 2022 to USD 4.5 trillion, or USD 13,493 per person. Health spending accounted for 17.3% of the nation's Gross Domestic Product. Source: CMS.gov. Therefore, such developments and investments are likely to have a positive impact on the growth of this end-user segment.

By geography, North America represented a major share in the Cochlear Implants Market in 2023, followed by Europe.

Major markets for cochlear implants include the six geographical divisions: North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC countries. In 2023, North America accounted for the largest share of the cochlear implants market due to rising healthcare expenditures and the region's technologically advanced healthcare infrastructure. This is facilitating early diagnosis and treatment of hearing impairments. The rising prevalence of hearing loss among pediatric and geriatric populations further supports market expansion. Government initiatives prevail for cochlear implants and their insurance coverage, increasing the adoption rate. Besides, continuous research and development by key players in this market contribute to advancements in the efficiency and accessibility of cochlear implant devices within the region. The major share of the US in the North American region can be attributed to the growing prevalence of hearing loss, increasing government funding, easy availability of audiologists, and rising healthcare expenditure.

In 2023, Europe held the second-largest share of the cochlear implants market. Europe is a mature and heterogeneous healthcare market, comprising many developed and emerging players, with huge country-level variation in terms of per-capita healthcare expenditure, reimbursement coverage, and market penetration of target products. In addition, fundamental long-term drivers, such as a high geriatric population and increasing prevalence of hearing loss in key countries, will also support the growth of the market.

HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION
Cochlear implants Market

Recent Developments of Cochlear implants Market

  • In September 2024, MED-EL Medical Electronics, Austria, launched the audio processor SONNET 3. This is an advanced BTE audio processor that boasts exceptional hearing performance and seamless connectivity for cochlear implant users. With state-of-the-art technology, the SONNET 3 will set another milestone in further improving the hearing experience and seamlessly integrating into daily life.
  • In May 2024, Cochlear Ltd. acquired Demant's Oticon Medical Cochlear Implant business. The acquisition strengthened Cochlear’s market position by expanding its customer base and technology portfolio.

Key Market Players

KEY PLAYERS IN THE COCHLEAR IMPLANTS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Cochlear Implants Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Value (USD Billion)
Segments covered Component Type, Type of Implants, Patient Type, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries

 

Key Questions Addressed by the Report

What are the driving factors for the cochlear implants market?
The cochlear implants market is being driven by an increasing incidence of hearing loss, especially in the geriatric population, besides advances in implant technology. More accessibility to these devices has come out through government programs, insurance covering for them, and awareness among people.
What is the global size of the cochlear implants market?
The cochlear implants market is projected to grow from USD 2.80 billion in 2024 to USD 4.73 billion by 2030, with a CAGR of 9.2% during the forecast period.
What types of patient type categories within the cochlear implant market? Where is the major segment when one considers targeting during 2023?
By patient type, the cochlear implants market has two categories; adults and pediatrics. The pediatrics category dominated the in year 2023. This can be attributed to increasing awareness for early invention concerning children, coupled with severe-to-profound hearing loss. Its technology advancement increases acceptance and helps become safer and more efficient when performed upon young children because these are the categories highly benefited from early implantations coupled with effective hearing rehabilitation.
What component types are included in the cochlear implants market? Which component type dominated the cochlear implants market in 2023?
The cochlear implant systems and upgrades & accessories are included in the component type segment. The cochlear implant systems dominated the segment share in 2023 due to the growing demand for the implants themselves as the first-line solution for severe to profound hearing loss. Implant devices have become more appealing to patients and healthcare professionals due to technological developments such enhanced sound processing, longer battery life, and connection functions.
Who are the end users of the cochlear implants? Which end user dominated the market in 2023?
Based on end users, the cochlear implants market is segmented into hospitals, ENT clinics, and other end users. The other end users segment comprises ambulatory surgery centers (ASCs) and cochlear implant centers. Hospitals accounted for the largest share of the cochlear implants market in 2023, primarily because their ability to offer specialized care for both the surgical procedure and extensive post-operative rehabilitation. With well-established medical infrastructure and a high concentration of skilled professionals, hospitals are the preferred setting for cochlear implantation.
Who are the key players in the cochlear implants market?
The key players in the cochlear implants market include Cochlear Ltd. (Australia), Sonova (Switzerland), MED-EL Medical Electronics (Austria), Zhejiang Nurotron Biotechnology Co., Ltd. (China), TODOC Co., Ltd. (South Korea), Neubio AG (Switzerland), and Shanghai Listent Medical Tech Co., Ltd. (China).
Which region is lucrative for the cochlear implants market?
The market is expected to record the highest growth in the Asia Pacific region during the forecast period. A strong growth potential is foreseen in emerging markets in the Asia Pacific, especially China and India, due to rising prevalence, improvement in access to healthcare, and awareness about cochlear implants as an effective solution for hearing loss.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cochlear Implants Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
22
RESEARCH METHODOLOGY
26
EXECUTIVE SUMMARY
41
PREMIUM INSIGHTS
45
MARKET OVERVIEW
50
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising prevalence of hearing impairment
    - Growing geriatric population
    - Comprehensive insurance coverage and favorable reimbursement policies
    RESTRAINTS
    - High cost of cochlear implants and associated surgeries
    - Surgical risks, procedural complications, and long post-surgery rehabilitation
    OPPORTUNITIES
    - Lucrative growth opportunities in emerging economies
    - Technological innovations in cochlear implants
    - Integration with digital health platforms
    CHALLENGES
    - Shortage of skilled professionals performing ENT procedures
    - Competition from alternative solutions
  • 5.3 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021–2023
    AVERAGE SELLING PRICE TREND COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021–2023
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.7 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.9 REGULATORY ANALYSIS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East
    - Africa
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 902140
    EXPORT DATA FOR HS CODE 902140
  • 5.11 PATENT ANALYSIS
    LIST OF MAJOR PATENTS
  • 5.12 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.14 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Electrode-based auditory nerve stimulation
    COMPLEMENTARY TECHNOLOGIES
    - Bimodal hearing solutions
    ADJACENT TECHNOLOGIES
    - Bone conduction hearing devices
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF AI/GEN AI ON COCHLEAR IMPLANTS MARKET
COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE
84
  • 6.1 INTRODUCTION
  • 6.2 COCHLEAR IMPLANT SYSTEMS
    INCREASED GERIATRIC POPULATION AND AVAILABILITY OF MEDICAL INSURANCE TO BOOST MARKET GROWTH
  • 6.3 UPGRADES & ACCESSORIES
    FOCUS ON TECHNOLOGICAL INNOVATIONS AND DEVICE PERSONALIZATION TO PROPEL MARKET GROWTH
COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT
93
  • 7.1 INTRODUCTION
  • 7.2 UNILATERAL IMPLANTS
    BETTER INSURANCE COVERAGE TO AID ADOPTION OF UNILATERAL IMPLANTS IN PATIENTS
  • 7.3 BILATERAL IMPLANTS
    IMPROVED SOUND LOCALIZATION AND SPEECH COMPREHENSION IN NOISY ENVIRONMENTS AMONG CHILDREN TO AUGMENT GROWTH
COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE
101
  • 8.1 INTRODUCTION
  • 8.2 ADULTS
    HIGHER SUSCEPTIBILITY TO HEARING LOSS IN GERIATRIC POPULATION TO FUEL ADOPTION OF COCHLEAR IMPLANTS
  • 8.3 PEDIATRICS
    EARLY DIAGNOSIS OF HEARING IMPAIRMENTS THROUGH NEWBORN SCREENING PROGRAMS TO SUPPORT MARKET GROWTH
COCHLEAR IMPLANTS MARKET, BY END USER
110
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    INCREASED ACCESS TO ADVANCED DIAGNOSTIC EQUIPMENT AND PRESENCE OF SKILLED SURGICAL TEAMS TO AID MARKET GROWTH
  • 9.3 ENT CLINICS
    INCREASING AWARENESS OF ENT-RELATED ISSUES AND GROWING NETWORK OF ADVANCED CLINICS TO AID GROWTH
  • 9.4 OTHER END USERS
COCHLEAR IMPLANTS MARKET, BY REGION
121
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American cochlear implants market during study period
    CANADA
    - Growing geriatric population and rising government health expenditure to propel market growth
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - High incidence of hearing impairment and favorable government health insurance schemes to augment growth
    UK
    - Increased prevalence of hearing problems among older adults to boost market growth
    FRANCE
    - Need for advanced treatment options and high government healthcare expenditure to spur market adoption
    ITALY
    - Well-developed healthcare system with high financial resources to fuel uptake of cochlear implants
    SPAIN
    - Long waiting times for ENT appointments and lack of reimbursement to limit market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Advanced healthcare system and rapidly growing geriatric population to support market growth
    CHINA
    - Modernization of healthcare facilities and increased patient pool to drive market
    INDIA
    - Higher incidence of hearing impairment and increased government funds to propel market growth
    AUSTRALIA
    - Increasing number of ENT specialists and rising government funding in public hospitals to support market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Favorable investment scenario from medical device manufacturers to favor market growth
    MEXICO
    - Increased FDI and growing presence of key healthcare companies to support market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    FOCUS ON HEALTHCARE SYSTEM MODERNIZATION AND INCREASED GOVERNMENT AWARENESS TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.7 GCC COUNTRIES
    EMPHASIS ON INFRASTRUCTURAL DEVELOPMENT AND HEALTHCARE ACCESS TO SUPPORT MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
178
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN COCHLEAR IMPLANTS MARKET
  • 11.3 REVENUE ANALYSIS, 2021–2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Component type footprint
    - Patient type footprint
    - End-user footprint
  • 11.6 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7 BRAND/PRODUCT COMPARISON
  • 11.8 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
191
  • 12.1 KEY PLAYERS
    COCHLEAR LTD.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SONOVA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MED-EL MEDICAL ELECTRONICS
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    - Business overview
    - Products offered
    NEUBIO AG
    - Business overview
    - Products offered
    TODOC CO., LTD.
    - Business overview
    - Products offered
    SHANGHAI LISTENT MEDICAL TECH CO., LTD.
    - Business overview
    - Products offered
APPENDIX
208
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 COCHLEAR IMPLANTS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 COCHLEAR IMPLANTS MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 3 COCHLEAR IMPLANTS MARKET: MARKET ASSUMPTIONS
  • TABLE 4 COCHLEAR IMPLANTS MARKET: RISK ASSESSMENT
  • TABLE 5 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION, 2023 VS. 2030 VS. 2050
  • TABLE 6 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT SYSTEMS, BY REGION, 2021–2023
  • TABLE 7 AVERAGE SELLING PRICE TREND OF COCHLEAR IMPLANT PRODUCTS, BY KEY PLAYER, 2021–2023
  • TABLE 8 COCHLEAR IMPLANTS MARKET: ROLE IN ECOSYSTEM
  • TABLE 9 COCHLEAR IMPLANTS MARKET: PORTER’S FIVE FORCES
  • TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 11 KEY BUYING CRITERIA FOR MAJOR END USERS
  • TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
  • TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 IMPORT DATA FOR HS CODE 902140, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 23 EXPORT DATA FOR HS CODE 902140, BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 24 COCHLEAR IMPLANTS MARKET: LIST OF MAJOR PATENTS
  • TABLE 25 COCHLEAR IMPLANTS MARKET: LIST OF KEY CONFERENCES & EVENTS,JANUARY 2025–DECEMBER 2026
  • TABLE 26 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 27 KEY COCHLEAR IMPLANT SYSTEMS AVAILABLE IN MARKET
  • TABLE 28 COCHLEAR IMPLANT SYSTEMS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 30 EUROPE: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 32 LATIN AMERICA: COCHLEAR IMPLANT SYSTEMS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 33 KEY COCHLEAR IMPLANT UPGRADES & ACCESSORIES AVAILABLE IN MARKET
  • TABLE 34 COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 35 NORTH AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 36 EUROPE: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 38 LATIN AMERICA: COCHLEAR IMPLANT UPGRADES & ACCESSORIES MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 39 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 40 COCHLEAR UNILATERAL IMPLANTS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 41 NORTH AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 42 EUROPE: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 44 LATIN AMERICA: COCHLEAR UNILATERAL IMPLANTS MARKET, BY COUNTRY,2022–2030 (USD MILLION)
  • TABLE 45 COCHLEAR BILATERAL IMPLANTS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 47 EUROPE: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 49 LATIN AMERICA: COCHLEAR BILATERAL IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 50 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 51 COCHLEAR IMPLANTS MARKET FOR ADULTS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 52 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 53 EUROPE: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 55 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ADULTS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 56 COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 57 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 58 EUROPE: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 60 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR PEDIATRICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 61 COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 62 COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 64 EUROPE: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 66 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 67 COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 69 EUROPE: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 71 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR ENT CLINICS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 72 COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 73 NORTH AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 74 EUROPE: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 76 LATIN AMERICA: COCHLEAR IMPLANTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 77 HEARING AIDS SOLD GLOBALLY, 2022–2030 (MILLION UNITS)
  • TABLE 78 COCHLEAR IMPLANTS MARKET, BY REGION, 2022–2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 80 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 82 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030(USD MILLION)
  • TABLE 84 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 85 US: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 86 US: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 87 US: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 88 US: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 89 CANADA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 90 CANADA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 91 CANADA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 92 CANADA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 93 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 94 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 95 EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 96 EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 97 EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 98 EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 99 GERMANY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 100 GERMANY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 101 GERMANY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 102 GERMANY: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 103 UK: NUMBER OF NEW COCHLEAR IMPLANT RECIPIENTS
  • TABLE 104 UK: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 105 UK: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 106 UK: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 107 UK: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 108 FRANCE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 109 FRANCE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 110 FRANCE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 111 FRANCE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 112 ITALY: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 113 ITALY: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 114 ITALY: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 115 ITALY: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 116 SPAIN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 117 SPAIN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 118 SPAIN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 119 SPAIN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 120 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 121 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 122 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 123 REST OF EUROPE: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 125 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 129 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 130 JAPAN: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 131 JAPAN: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 132 JAPAN: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 133 JAPAN: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 134 CHINA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 135 CHINA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 136 CHINA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 137 CHINA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 138 INDIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 139 INDIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 140 INDIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 141 INDIA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 142 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 143 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 144 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 145 AUSTRALIA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 146 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 147 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 148 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 149 REST OF ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 150 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 151 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
  • TABLE 152 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 153 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 154 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 155 LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 156 BRAZIL: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 157 BRAZIL: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 158 BRAZIL: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 159 BRAZIL: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 160 MEXICO: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 161 MEXICO: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 162 MEXICO: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 163 MEXICO: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 164 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 165 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 166 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 167 REST OF LATIN AMERICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 169 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: MACROECONOMIC INDICATORS
  • TABLE 174 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2022–2030 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2022–2030 (USD MILLION)
  • TABLE 177 GCC COUNTRIES: COCHLEAR IMPLANTS MARKET, BY END USER, 2022–2030 (USD MILLION)
  • TABLE 178 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS IN COCHLEAR IMPLANTS MARKET
  • TABLE 179 COCHLEAR IMPLANTS MARKET: DEGREE OF COMPETITION
  • TABLE 180 COCHLEAR IMPLANTS MARKET: REGION FOOTPRINT
  • TABLE 181 COCHLEAR IMPLANTS MARKET: COMPONENT TYPE FOOTPRINT
  • TABLE 182 COCHLEAR IMPLANTS MARKET: PATIENT TYPE FOOTPRINT
  • TABLE 183 COCHLEAR IMPLANTS MARKET: END-USER FOOTPRINT
  • TABLE 184 COCHLEAR IMPLANTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 185 COCHLEAR IMPLANTS MARKET: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 186 COCHLEAR IMPLANTS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
  • TABLE 187 COCHLEAR LTD.: COMPANY OVERVIEW
  • TABLE 188 COCHLEAR LTD.: PRODUCTS OFFERED
  • TABLE 189 COCHLEAR LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–DECEMBER 2024
  • TABLE 190 COCHLEAR LTD.: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 191 SONOVA: COMPANY OVERVIEW
  • TABLE 192 EXCHANGE RATES USED FOR CONVERSION OF CHF TO USD
  • TABLE 193 SONOVA: PRODUCTS OFFERED
  • TABLE 194 SONOVA: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
  • TABLE 195 MED-EL MEDICAL ELECTRONICS: COMPANY OVERVIEW
  • TABLE 196 MED-EL MEDICAL ELECTRONICS: PRODUCTS OFFERED
  • TABLE 197 MED-EL MEDICAL ELECTRONICS: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024
  • TABLE 198 MED-EL MEDICAL ELECTRONICS: DEALS, JANUARY 2021–DECEMBER 2024
  • TABLE 199 MED-EL MEDICAL ELECTRONICS: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024
  • TABLE 200 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 201 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 202 NEUBIO AG: COMPANY OVERVIEW
  • TABLE 203 NEUBIO AG: PRODUCTS OFFERED
  • TABLE 204 TODOC CO., LTD.: COMPANY OVERVIEW
  • TABLE 205 TODOC CO., LTD.: PRODUCTS OFFERED
  • TABLE 206 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 207 SHANGHAI LISTENT MEDICAL TECH CO., LTD.: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 COCHLEAR IMPLANTS MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
  • FIGURE 2 COCHLEAR IMPLANTS MARKET: YEARS CONSIDERED
  • FIGURE 3 COCHLEAR IMPLANTS MARKET: RESEARCH DESIGN
  • FIGURE 4 COCHLEAR IMPLANTS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 COCHLEAR IMPLANTS MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 COCHLEAR IMPLANTS MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 7 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 8 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 COCHLEAR IMPLANTS MARKET: REVENUE SHARE ANALYSIS
  • FIGURE 10 COUNTRY-BASED APPROACH FOR ESTIMATING GLOBAL MARKET SIZE
  • FIGURE 11 COCHLEAR IMPLANTS MARKET: APPROACH FOR ESTIMATING GLOBAL MARKET SIZE BASED ON UNITS SOLD
  • FIGURE 12 COCHLEAR IMPLANTS MARKET: CAGR PROJECTIONS (SUPPLY SIDE)
  • FIGURE 13 COCHLEAR IMPLANTS MARKET: TOP-DOWN APPROACH
  • FIGURE 14 COCHLEAR IMPLANTS MARKET: DATA TRIANGULATION
  • FIGURE 15 COCHLEAR IMPLANTS MARKET, BY COMPONENT TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 16 COCHLEAR IMPLANTS MARKET, BY TYPE OF IMPLANT, 2024 VS. 2030 (USD MILLION)
  • FIGURE 17 COCHLEAR IMPLANTS MARKET, BY PATIENT TYPE, 2024 VS. 2030 (USD MILLION)
  • FIGURE 18 COCHLEAR IMPLANTS MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)
  • FIGURE 19 COCHLEAR IMPLANTS MARKET: REGIONAL SNAPSHOT
  • FIGURE 20 INCREASING PATIENT POOL AND RISING HEALTHCARE EXPENDITURE TO DRIVE MARKET
  • FIGURE 21 US AND COCHLEAR IMPLANT SYSTEMS COMMANDED LARGEST MARKET SHARE IN 2023
  • FIGURE 22 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030
  • FIGURE 23 ASIA PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING STUDY PERIOD
  • FIGURE 24 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 25 COCHLEAR IMPLANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 COCHLEAR IMPLANTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 27 COCHLEAR IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 28 COCHLEAR IMPLANTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 KEY PLAYERS IN COCHLEAR IMPLANTS MARKET ECOSYSTEM
  • FIGURE 30 COCHLEAR IMPLANTS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 32 KEY BUYING CRITERIA FOR MAJOR END USERS
  • FIGURE 33 PATENT ANALYSIS FOR COCHLEAR IMPLANTS, JANUARY 2014–DECEMBER 2024
  • FIGURE 34 COCHLEAR IMPLANTS MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 35 COCHLEAR IMPLANTS MARKET: FUNDING AND NUMBER OF DEALS, 2020–2024
  • FIGURE 36 NORTH AMERICA: COCHLEAR IMPLANTS MARKET SNAPSHOT
  • FIGURE 37 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET SNAPSHOT
  • FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET, 2021–2023
  • FIGURE 39 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COCHLEAR IMPLANTS MARKET (2023)
  • FIGURE 40 COCHLEAR IMPLANTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 41 COCHLEAR IMPLANTS MARKET: COMPANY FOOTPRINT
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 COCHLEAR IMPLANTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 COCHLEAR LTD.: COMPANY SNAPSHOT
  • FIGURE 46 SONOVA: COMPANY SNAPSHOT

To determine the current size of the cochlear implants market, this study engaged in four main activities. A comprehensive study was conducted using secondary research methods to gather data about the market, dits parent market, and its peer markets. The next stage involved conducting primary research to confirm these conclusions, assumptions, and sizing with industry experts throughout the value chain. A combination of top-down and bottom-up methods was used to assess the overall market size. The market sizes of segments and subsegments were then estimated using data triangulation techniques and market breakdown.

The four steps involved in estimating the market size are

Secondary Research

Within the secondary data collection process, a range of secondary sources were reviewed so as to identify and gather data for this study, including regulatory bodies, databases (like D&B Hoovers, Bloomberg Business, and Factiva), white papers, certified publications, articles by well-known authors, annual reports, press releases, and investor presentations of companies.

Primary Research

In the primary research phase, a comprehensive approach was employed, involving the interviewing of several sources from both the supply and demand sides. The purpose of these interviews was to obtain the quantitative and qualitative information needed to put up this report. The main sources of information were industry experts from both core and related sectors, as well as preferred manufacturers, distributors, suppliers, pioneers in technology, and organizations involved in every aspect of this industry's value chain. A variety of primary respondents, including important industry stakeholders, subject-matter experts, C-level executives from crucial market companies, and industry advisers, were carefully questioned in-depth. The goal was to gather and validate important qualitative and quantitative insights and to conduct a thorough assessment of future possibilities. A breakdown of the primary respondents is provided below:

The following is a breakdown of the primary respondents:

Cochlear implants Market

Note 1: Others include sales, marketing, and product managers.

Note 2: Tiers of companies are defined based on their total revenue. As of 2023, Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME DESIGNATION
Cochlear Ltd. (Australia) Area Manager
Sonova (Switzerland) Marketing Manger
MED-EL Medical Electronics (Austria) Clinical Specialist

Market Size Estimation

All major product providers offering various products and services were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value of the cochlear implants market was also split into various segments and subsegments at the region and country level based on:

  • Offering mapping of various manufacturers for each type in the cochlear implants market at the regional and country-level
  • Relative adoption pattern of cochlear implants market among key application segments at the regional and/or country-level
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country level

Both top-down and bottom-up approaches were used to estimate and validate the total size of cochlear implants market.

Cochlear implants Market

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. By examining a number of variables and patterns from the supply and demand sides, the data was triangulated.

Market Definition

A cochlear implant is a medical device for individuals with severe to profound hearing loss. It consists of an internal unit, including an electrode array surgically implanted into the cochlea, and an external unit, featuring a sound processor to capture and process sound.

The use of a cochlear implant involves undergoing a surgical procedure followed by extensive therapy to develop or regain the ability to hear.

Stakeholders

  • Cochlear implant systems manufacturers
  • Suppliers and Distributors of Cochlear Implants
  • Hospitals
  • ENT Clinics
  • Ambulatory Surgery Centers
  • Cochlear Implant Centers
  • Audiologists
  • ENT Specialists
  • Rehabilitation Centers
  • Surgeons and Medical Staff
  • Healthcare Providers
  • Market Research and Consulting Firms
  • Government Associations
  • Venture Capitalists and Investors

Report Objectives

  • To define, describe, segment, and forecast the cochlear implants market by component type, type of implants, patient type, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To assess the cochlear implants market with respect to Porter’s five forces, regulatory landscape, the value chain, the supply chain, ecosystem analysis, patent protection, pricing assessment, key stakeholders, and buying criteria
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall cochlear implants market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to six regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To track and analyze company developments such as product launches, approvals, acquisitions, agreements, partnerships, and other developments such as regulatory approvals.
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
  • To analyze impact of AI on the cochlear implants market

Previous Versions of this Report

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cochlear Implants Market

DMCA.com Protection Status